| Primary |
|
| Syncope |
66.7% |
| Hepatic Enzyme Increased |
33.3% |
|
| Secondary |
| Pulmonary Tuberculosis |
61.3% |
| Tuberculosis |
17.7% |
| Mycobacterial Infection |
9.7% |
| Carcinoma Hepatocellular |
1.6% |
| Hepatitis C |
1.6% |
| Hyperammonaemia |
1.6% |
| Malaise |
1.6% |
| Open Angle Glaucoma |
1.6% |
| Pyrexia |
1.6% |
| Vitamin Supplementation |
1.6% |
|
| Delusional Disorder, Mixed Type |
28.6% |
| Thrombocytopenia |
21.4% |
| Hyperglycaemia |
14.3% |
| Conjunctival Oedema |
7.1% |
| Gastrointestinal Necrosis |
7.1% |
| Pneumocystis Jiroveci Pneumonia |
7.1% |
| Treatment Noncompliance |
7.1% |
| Vomiting |
7.1% |
|
| Concomitant |
| Hepatic Cirrhosis |
14.2% |
| Product Used For Unknown Indication |
10.2% |
| Pulmonary Tuberculosis |
9.5% |
| Prophylaxis |
7.2% |
| Hepatic Neoplasm Malignant |
7.0% |
| Tuberculosis |
6.6% |
| Neoplasm Malignant |
6.1% |
| Mycobacterium Avium Complex Infection |
5.7% |
| Coronary Artery Bypass |
4.2% |
| Hepatitis B |
3.8% |
| Insomnia |
3.8% |
| Antibiotic Prophylaxis |
2.5% |
| Depression |
2.5% |
| Lung Neoplasm Malignant |
2.5% |
| Non-alcoholic Steatohepatitis |
2.5% |
| Parkinson's Disease |
2.5% |
| Prostate Cancer |
2.5% |
| Analgesic Therapy |
2.1% |
| Ascites |
2.1% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
2.1% |
|
| Psychotic Disorder |
8.5% |
| Confusional State |
7.4% |
| Renal Failure |
7.4% |
| Epilepsy |
6.4% |
| Stevens-johnson Syndrome |
6.4% |
| Transfusion |
6.4% |
| Vomiting |
6.4% |
| Hepatic Failure |
5.3% |
| Pleural Effusion |
5.3% |
| Convulsion |
4.3% |
| Diarrhoea |
4.3% |
| Liver Disorder |
4.3% |
| Pyrexia |
4.3% |
| Rash |
4.3% |
| Depression |
3.2% |
| Hepatic Encephalopathy |
3.2% |
| Memory Impairment |
3.2% |
| Renal Impairment |
3.2% |
| Thirst |
3.2% |
| Thrombophlebitis |
3.2% |
|
